Skip to content
akaturk Academic measurement
Sign in Sign up

OpenAlex topic

Neuroendocrine Tumor Research Advances

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 3,514 works 34 author topics

Works

3,514 works

  1. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial 2019
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  2. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial 2019
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  3. Durvalumab plus platinum\u2013etoposide versus platinum\u2013etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial 2019
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  4. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model 2003
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.5%

    No abstract yet.

  5. Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA. 2017
    YÖKSİS OpenAlex top 1% OpenAlex 99.7%

    No abstract yet.

  6. The mammary gland iodide transporter is expressed during lactation and in breast cancer 2000
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%

    No abstract yet.

  7. The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms 2015
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%

    The 2010 World Health Organization (WHO) classification recommends that pancreatic neuroendocrine tumors (PanNETs) be graded on the basis of the mitotic rate and Ki67 index, with grade 2 (G2) PanNETs defined as having a mitotic rate of 2 to 20 mitotic figures/10 high-power fields or a Ki67 index of 3% to 20%. Grade 3…

  8. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer 2004
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%

    No abstract yet.

  9. A randomized clinical trial of combination chemotherapy with and without low molecular weight heparin in small cell lung cancer 2004
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%

    No abstract yet.

  10. A randomized clinical trial of combination chemotherapy with and without low‐molecular‐weight heparin in small cell lung cancer 2004
    OpenAlex top 1% OpenAlex 99.6%

    No abstract yet.

  11. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature 2004
    YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 95.5%

    No abstract yet.

  12. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature 2004
    YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 95.5%

    No abstract yet.

Academicians

34 academicians